The global intellectual property ecosystem for insulin and its public health implications: an observational study.
作者: Kaplan Warren ABeall Reed F
作者单位: 1Department of Global Health, Boston University School of Public Health, Boston, MA 02118 USA.
2Population Health Program, Faculties of Medicine and of Law, University of Ottawa, One Stewart St, Ottawa, ON K1N 6N5 Canada.
刊名: Journal of pharmaceutical policy and practice, 2017, Vol.10 , pp.3
来源数据库: PubMed Journal
DOI: 10.1186/s40545-016-0072-8
关键词: Generic medicineIntellectual propertyPatentPharmaceutical policy
原始语种摘要: Lack of access to insulin and poor health outcomes are issues for both low and high income countries. This has been accompanied by a shift from relatively inexpensive human insulin to its more expensive analogs, marketed by three to four main global players. Nonetheless, patent-based market exclusivities are beginning to expire there for the first generation insulin analogs. This paper adds a global dimension to information on the U.S. patent landscape for insulin by reviewing the patent status of insulins with emphasis on the situation outside the US and Europe.;;Using the term "insulin", we searched for patents listed on the United States Food and Drug Administration's (USFDA) Orange Book and the Canadian Online Drug Product Database Online Query and its Patent Register. With this...
全文获取路径: PubMed  (合作)

  • insulin 胰岛素
  • global 球状的
  • patent 专利的
  • Patent 帕滕特<派吞特>牌手表
  • market 市场
  • filings 锉屑
  • income 收入
  • property 所有权
  • diversify 多样化
  • country 地方